Current state of the red scrotum syndrome
- Authors: Abuduyev N.K.1, Plahova X.I.1, Katunin G.L.1
-
Affiliations:
- State Research Center of Dermatovenereology and Cosmetology
- Issue: Vol 98, No 5 (2022)
- Pages: 53-58
- Section: REVIEWS
- URL: https://ogarev-online.ru/0042-4609/article/view/117639
- DOI: https://doi.org/10.25208/vdv1357
- ID: 117639
Cite item
Full Text
Abstract
Red scrotum syndrome is a chronic, difficult-to-recognize dermatosis affecting middle-aged and elderly people. It is manifested by erythema of the scrotum with clear boundaries, without neck. The etiology and pathogenesis of the disease have not been established. Hypotheses about the causes of dermatosis as a consequence of uncontrolled use of topical steroids, neurological inflammation, formation of microbial biofilm are based on anamnestic data and the results of trial treatments. Etiologically and pathogenetically justified therapy has not been proposed. Therapy with the use of doxycycline, gabapentin, pregabalin, indomethacin, tacrolimus was carried out in small groups of patients. The lack of clarity in the etiology and understanding of the mechanism of development of the disease explains the lack of a unified focus of the proposed therapies based on isolated clinical cases. In general, the problem of diagnosis and treatment rests on the absence of major clinical, epidemiological and laboratory studies that allowed to establish the pathophysiology and assess the true prevalence of red scrotum syndrome.
Full Text
##article.viewOnOriginalSite##About the authors
Nazirbek K. Abuduyev
State Research Center of Dermatovenereology and Cosmetology
Author for correspondence.
Email: abuduyevnk@mail.ru
ORCID iD: 0000-0002-6550-9348
SPIN-code: 5805-3882
MD, Dr. Sci. (Med.)
Russian Federation, Korolenko str., 3, bldg 6, 107076, MoscowXenia I. Plahova
State Research Center of Dermatovenereology and Cosmetology
Email: plahova_xenia@mail.ru
ORCID iD: 0000-0003-4169-4128
SPIN-code: 7634-5521
MD, Dr. Sci. (Med.)
Russian Federation, Korolenko str., 3, bldg 6, 107076, MoscowGeorgiy L. Katunin
State Research Center of Dermatovenereology and Cosmetology
Email: g.katunin@rambler.ru
ORCID iD: 0000-0003-0599-6305
SPIN-code: 1598-8595
MD, Cand. Sci. (Med.)
Russian Federation, Korolenko str., 3, bldg 6, 107076, MoscowReferences
- Fisher BK. The red scrotum syndrome. Cutis. 1997;60(3):139–141.
- Rubin MB. Red scrotum syndrome. Cutis. 1998;61(1):28D.
- Rapaport MJ. Red scrotum syndrome. Cutis. 1998;61(3):128B.
- Khalil S, Kurban M, Abbas O. Red scrotum syndrome: An update on clinicopathologic features, pathogenesis, diagnosis, and management. J Am Acad Dermatol. 2022;87(3):614–622. doi: 10.1016/j.jaad.2020.05.113
- Abbas O, Kibbi AG, Chedraoui A, Ghosn S. Red scrotum syndrome: successful treatment with oral doxycycline. J Dermatolog Treat. 2008;19(6):1–2. doi: 10.1080/09546630802033858
- Narang T, Kumaran MS, Dogra S, Saikia UN, Kumar B. Red scrotum syndrome: idiopathic neurovascular phenomenon or steroid addiction? Sex Health. 2013;10(5):452–455. doi: 10.1071/SH13052
- Wollina U. Three orphans one should know: red scalp, red ear and red scrotum syndrome. J Eur Acad Dermatol Venereol. 2016;30(11):169–170. doi: 10.1111/jdv.13474.
- Verma SB, Wollina U, Das A. A curious observation of passive transfer of steroid antifungal combination creams to the scrotum in patients of tinea cruris-Is this forme fruste of red scrotum syndrome? Dermatol Ther. 202033(6):14212. doi: 10.1111/dth.14212
- Khalil S, Kurban M, Abbas O. Red scrotum syndrome: An update on clinicopathologic features, pathogenesis, diagnosis, and management. J Am Acad Dermatol. 2022;87(3):614–622. doi: 10.1016/j.jaad.2020.05.113
- Martinez JD, Soria Orozco M, Cardenas-de la Garza JA. Oral ivermectin for the treatment of red scrotum syndrome. J Dermatolog Treat. 2022;33(2):1102–1103. doi: 10.1080/09546634.2020.1773378
- Rapaport MJ, Rapaport VH. Serum nitric oxide levels in "red" patients: separating corticosteroid-addicted patients from those with chronic eczema. Arch Dermatol. 2004;140(8):1013–1014. doi: 10.1001/archderm.140.8.1013
- Rapaport M. Rebound vasodilation from long-term topical corticosteroid use. Arch Dermatol. 2007;143(2):268–269. doi: 10.1001/archderm.143.2.268-b
- Prevost N, English JC. Case reports: red scrotal syndrome: a localized phenotypical expression of erythromelalgia.3 J Drugs Dermatol. 2007;6(9):935–936.
- Wollina U. Red scrotum syndrome. Dermatol Case Rep. 2011;5(3):38–41. doi: 10.3315/jdcr.2011.1072
- Markos AR, Dinsmore W. Persistent genital arousal and restless genitalia: sexual dysfunction or subtype of vulvodynia? Int J STD AIDS. 2013;24(11):852–858. doi: 10.1177/0956462413489276
- Miller J, Leicht S. Pregabalin in the treatment of red scrotum syndrome: a report of two cases. Dermatol Ther. 2016;29(4):244–248. doi: 10.1111/dth.12354
- Mizes A, Bunimovich O, Bunimovich YuL. Combined carvedilol and gabapentin treatment induces a rapid response in red scrotum syndrome. Dermatol Online J. 2021;27(5). doi: 10.5070/D327553619
- Thompson GH, Hahn G, Rang M. Erythromelalgia. Clin Orthop Relat Res. 1979;(144):249–254.
- Perry TW. Cutaneous microbial biofilm formation as an underlying cause of red scrotum syndrome. Eur J Med Res. 2021;26(1):95. doi: 10.1186/s40001-021-00569-9
- Romano C, Ghilardi A, Papini M. Nine male cases of tinea genitalis. Mycoses. 2005;48(3):202–204. doi: 10.1111/j.1439-0507.2005.01127.x
- Merhi R, Ayoub N, Mrad M. Carvedilol for the treatment of red scrotum syndrome. JAAD Case Rep. 2017;3(5):464–466. doi: 10.1016/j.jdcr.2017.06.021
- Griffin MO, Fricovsky E, Ceballos G, Villarreal F. Tetracyclines: a pleitropic family of compounds with promising therapeutic properties. Review of the literature. Am J Physiol Cell Physiol. 2010;299(3):539–548. doi: 10.1152/ajpcell.00047.2010
- Byun JW, Hong WK, Han SH, Song HJ, Lee HS, Choi GS, et al. Red scrotum syndrome: successful treatment with oral doxycycline. Int J Dermatol. 2012;51(3):362–363. doi: 10.1111/j.1365-4632.2010.04548.x
- Ceyhan AM, Gurses I, Yildirim M, Akkaya VB. A case of erythromelalgia: good response to treatment with gabapentin. J Drugs Dermatol. 2010;9(5):565–567.
- Moore RA, Wiffen PJ, Derry S, Toelle T, Rice ASC. Gabapentin for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev. 2014(4):CD007938. doi: 10.1002/14651858.CD007938.pub3
- Cardenas-de la Garza JA, Villarreal-Villarreal CD, Cuellar-Barboza A, Cardenas-Gonzalez RE, Gonzalez-Benavides N, Cruz-Gomez LG, et al. Red Scrotum Syndrome Treatment with Pregabalin: A Case Series. Ann Dermatol. 2019;31(3):320–324. doi: 10.5021/ad.2019.31.3.320
- Toth C. Pregabalin: latest safety evidence and clinical implications for the management of neuropathic pain. Ther Adv Drug Saf. 2014;5(1):38–56. doi: 10.1177/2042098613505614
- Finnerup NB, Attal N, Haroutounian S, McNicol E, Baron R, Dworkin RH, et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol. 2015;14(2):162–173. doi: 10.1016/S1474-4422(14)70251-0
- Wang BCM, Liu D, Furnback WE, Bifa F, Dong P, Xie L, et al. The Cost-Effectiveness of Pregabalin Versus Gabapentin for Peripheral Neuropathic Pain (pNeP) and Postherpetic Neuralgia (PHN) in China. Pain Ther. 2016;5(1):81–91. doi: 10.1007/s40122-016-0048-z
- Hwang AS, Costello CM, Yang YW. Rapid improvement of burning scrotum syndrome with indomethacin. JAAD Case Rep. 2021;12:32–33. doi: 10.1016/j.jdcr.2021.03.050
- Pyle TM, Heymann WR. Managing red scrotum syndrome (RSS) with topical timolol. Int J Dermatol. 2019;58(8):162–163. doi: 10.1111/ijd.14463
- Alzaid M, Al-Naseem A, Al-Niaimi F, Ali FR. Topical timolol in dermatology: infantile haemangiomas and beyond. Clin Exp Dermatol. 2022;47(5):819–832. doi: 10.1111/ced.15021
Supplementary files
